China’s CoronaVac Trial Resumes in Brazil After ‘Adverse Event’

(Bloomberg) -- Brazil reversed its decision to suspend trials of a coronavirus vaccine from Chinese developer Sinovac Biotech Ltd., allowing tests to resume less than 48 hours after being halted am...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.